$XCUR
Exicure Inc

2024 Q3 Form 10-Q Financial Statement

#000169853024000089 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q4
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.235M $1.498M
YoY Change -73.84% -28.9%
% of Gross Profit
Research & Development $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit
Depreciation & Amortization $7.000K $7.000K
YoY Change -96.93% -97.51%
% of Gross Profit
Operating Expenses $2.572M $1.235M $1.498M
YoY Change -22.46% -78.11% -52.89%
Operating Profit -$2.572M -$1.235M
YoY Change -22.46% -78.11%
Interest Expense -$2.000K $11.00K
YoY Change -59.26%
% of Operating Profit
Other Income/Expense, Net $1.489M $635.0K $0.00
YoY Change -176.79% -620.49% -100.0%
Pretax Income -$1.083M -$600.0K -$1.487M
YoY Change -79.39% -89.59% -107.99%
Income Tax $8.000K $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.091M -$600.0K -$1.487M
YoY Change -79.24% -89.59% -108.08%
Net Earnings / Revenue
Basic Earnings Per Share -$0.57 -$0.07
Diluted Earnings Per Share -$0.57 -$0.07 -$0.17
COMMON SHARES
Basic Shares Outstanding 8.651M shares 8.651M shares
Diluted Shares Outstanding 1.899M shares 8.651M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $528.0K $816.0K
YoY Change -77.39% -90.49%
Cash & Equivalents $343.0K $528.0K $816.0K
Short-Term Investments
Other Short-Term Assets $992.0K $1.193M
YoY Change -25.36% -19.06%
Inventory
Prepaid Expenses $0.00
Receivables
Other Receivables
Total Short-Term Assets $2.600M $2.079M $2.024M
YoY Change -15.86% -43.26% -79.86%
LONG-TERM ASSETS
Property, Plant & Equipment $33.00K $40.00K $54.00K
YoY Change -45.9% -97.77% -97.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.072M $2.443M $2.985M
YoY Change -32.99% -53.04% -14.47%
Total Long-Term Assets $8.031M $8.609M $9.556M
YoY Change -18.55% -38.02% -28.03%
TOTAL ASSETS
Total Short-Term Assets $2.600M $2.079M $2.024M
Total Long-Term Assets $8.031M $8.609M $9.556M
Total Assets $10.63M $10.69M $11.58M
YoY Change -17.91% -39.12% -50.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.337M $1.585M $1.631M
YoY Change 54.57% 362.1% 351.8%
Accrued Expenses $2.318M $846.0K $879.0K
YoY Change 70.94% -22.24% -31.22%
Deferred Revenue
YoY Change
Short-Term Debt $1.000M $0.00
YoY Change
Long-Term Debt Due $1.000M $0.00
YoY Change
Total Short-Term Liabilities $3.655M $3.431M $2.510M
YoY Change 64.57% 139.76% 53.14%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.644M $6.039M
YoY Change -12.07%
Total Long-Term Liabilities $5.644M $6.039M
YoY Change -12.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.655M $3.431M $2.510M
Total Long-Term Liabilities $5.644M $6.039M
Total Liabilities $9.086M $9.075M $8.549M
YoY Change 7.5% 15.61% 1.7%
SHAREHOLDERS EQUITY
Retained Earnings -$192.1M -$191.0M -$189.6M
YoY Change 2.13% 9.8%
Common Stock $0.00 $1.000K $1.000K
YoY Change -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.545M $1.613M $3.031M
YoY Change
Total Liabilities & Shareholders Equity $10.63M $10.69M $11.58M
YoY Change -17.91% -39.12% -50.36%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q4
OPERATING ACTIVITIES
Net Income -$1.091M -$600.0K -$1.487M
YoY Change -79.24% -89.59% -108.08%
Depreciation, Depletion And Amortization $7.000K $7.000K
YoY Change -96.93% -97.51%
Cash From Operating Activities -$1.166M -$816.0K
YoY Change -75.76% -88.79%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $711.0K
YoY Change -100.0% 243.48%
Cash From Investing Activities $0.00 $711.0K
YoY Change -100.0% 243.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.000M -1.000K
YoY Change -208.81%
NET CHANGE
Cash From Operating Activities -1.166M -816.0K
Cash From Investing Activities 0.000 711.0K
Cash From Financing Activities 1.000M -1.000K
Net Change In Cash -166.0K -106.0K
YoY Change -97.82% -98.5%
FREE CASH FLOW
Cash From Operating Activities -$1.166M -$816.0K
Capital Expenditures $0.00
Free Cash Flow -$816.0K
YoY Change -88.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Investment Income Dividend
InvestmentIncomeDividend
32000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-600000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2016000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1235000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1235000 usd
CY2024Q2 us-gaap Investment Income Dividend
InvestmentIncomeDividend
1000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
635000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-600000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8432394 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8432394 shares
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3431000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5644000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
9075000 usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-600000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
192604000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190992000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1613000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10688000 usd
us-gaap Operating Expenses
OperatingExpenses
10181000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10181000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-829000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1400000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
24000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5764000 usd
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1000000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2510000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6039000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8549000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8650753 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8650753 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
192593000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-189563000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3031000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11580000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1423000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8758000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
5642000 usd
us-gaap Operating Expenses
OperatingExpenses
2571000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5642000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2071000 usd
CY2023Q2 us-gaap Investment Income Dividend
InvestmentIncomeDividend
15000 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
5000 usd
CY2024Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6000 usd
CY2023Q2 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
6000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
637000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
637000 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-150000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-122000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
642000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5764000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1429000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10171000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-1429000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10171000 usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8651078 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8651078 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8650878 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8650878 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7366594 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7366594 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3031000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
2207000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1613000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
14922000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
308000 usd
CY2023Q1 xcur Adjustments To Additional Paid In Capital Decrease Related To Reclassification
AdjustmentsToAdditionalPaidInCapitalDecreaseRelatedToReclassification
800000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4597000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4407000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
14619000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
969000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-119000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5764000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9705000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1429000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10171000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
14000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
479000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
11000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1277000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
390000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
364000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-44000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
544000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-415000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-145000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-288000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-46000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-32000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-190000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-395000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-347000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1616000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8129000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
2000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
211000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1789000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1000000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5440000 usd
xcur Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
0 usd
xcur Payments Of Common Stock Financing Costs
PaymentsOfCommonStockFinancingCosts
843000 usd
xcur Payment For Exercise Of Common Stock Warrant
PaymentForExerciseOfCommonStockWarrant
0 usd
xcur Payment For Exercise Of Common Stock Warrant
PaymentForExerciseOfCommonStockWarrant
800000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
121000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3676000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-616000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6242000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9777000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3535000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
528000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
816000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
872000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1200000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1400000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2016000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
528000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div>The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on certain assumptions which it believes are reasonable in the circumstances and while actual results could differ from those estimates, management does not believe that any change in those assumptions in the near term would have a significant effect on the Company’s financial position, results of operations or cash flows. Actual results in future periods could differ from those estimates.
CY2024Q2 us-gaap Prepaid Insurance
PrepaidInsurance
476000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
508000 usd
CY2024Q2 xcur Prepaid Franchise Tax
PrepaidFranchiseTax
61000 usd
CY2023Q4 xcur Prepaid Franchise Tax
PrepaidFranchiseTax
259000 usd
CY2024Q2 xcur Lease Cost Current
LeaseCostCurrent
255000 usd
CY2023Q4 xcur Lease Cost Current
LeaseCostCurrent
235000 usd
CY2024Q2 xcur Prepaid Professional Fees Current
PrepaidProfessionalFeesCurrent
70000 usd
CY2023Q4 xcur Prepaid Professional Fees Current
PrepaidProfessionalFeesCurrent
95000 usd
CY2024Q2 xcur Prepaid Software Current
PrepaidSoftwareCurrent
62000 usd
CY2023Q4 xcur Prepaid Software Current
PrepaidSoftwareCurrent
72000 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
68000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
24000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
992000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1193000 usd
CY2024Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
872000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1200000 usd
CY2024Q2 xcur Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
1571000 usd
CY2023Q4 xcur Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
1785000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2443000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2985000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
279000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
279000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
239000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
225000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
14000 usd
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
479000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
671000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
626000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
175000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
182000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
846000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
879000 usd
CY2024Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
142000 usd
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
326000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
285000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
652000 usd
CY2024Q2 xcur Variable Lease Cost Net
VariableLeaseCostNet
-117000 usd
CY2023Q2 xcur Variable Lease Cost Net
VariableLeaseCostNet
-19000 usd
xcur Variable Lease Cost Net
VariableLeaseCostNet
3000 usd
xcur Variable Lease Cost Net
VariableLeaseCostNet
313000 usd
CY2024Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
9000 usd
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
20000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
0 usd
CY2024Q2 us-gaap Lease Cost
LeaseCost
34000 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
307000 usd
us-gaap Lease Cost
LeaseCost
308000 usd
us-gaap Lease Cost
LeaseCost
965000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
327000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
860000 usd
CY2024Q2 us-gaap Sublease Income
SubleaseIncome
173000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
346000 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
CY2024Q2 us-gaap Sublease Income
SubleaseIncome
173000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
346000 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
CY2024Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
0 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8651148 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8651148 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8650753 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8650753 shares
CY2024Q2 xcur Common Stock Voting Rights For Each Share
CommonStockVotingRightsForEachShare
1 vote
CY2022Q3 xcur Registration Rights Agreement Required Filing Term
RegistrationRightsAgreementRequiredFilingTerm
P90D
CY2022Q3 xcur Registration Rights Agreement Liquidation Damages Payable As A Percent Of Amount Invested If Filed Late
RegistrationRightsAgreementLiquidationDamagesPayableAsAPercentOfAmountInvestedIfFiledLate
0.005
CY2022Q3 xcur Registration Rights Agreement Liquidation Damages Payable If Filed Late Measurement Term
RegistrationRightsAgreementLiquidationDamagesPayableIfFiledLateMeasurementTerm
P30D
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 xcur Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
11478000 usd
CY2021Q4 xcur Proceeds From Issuance Of Common Stock And Warrants Net Of Placement Agent Fee And Other Offering Expenses Payable
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfPlacementAgentFeeAndOtherOfferingExpensesPayable
10226000 usd
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q4 xcur Class Of Warrant Or Right Ownership Percentage Limitation
ClassOfWarrantOrRightOwnershipPercentageLimitation
0.0499
CY2021Q4 xcur Class Of Warrant Or Right Ownership Percentage Limitation At Election Of Purchaser
ClassOfWarrantOrRightOwnershipPercentageLimitationAtElectionOfPurchaser
0.0999
CY2021Q4 xcur Class Of Warrant Or Right Ownership Percentage Limitation
ClassOfWarrantOrRightOwnershipPercentageLimitation
0.0499
CY2021Q4 xcur Class Of Warrant Or Right Ownership Percentage Limitation At Election Of Purchaser
ClassOfWarrantOrRightOwnershipPercentageLimitationAtElectionOfPurchaser
0.0999
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
576261 shares
CY2021Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.1031
CY2023Q2 xcur Class Of Warrant Or Right Payment For Liability
ClassOfWarrantOrRightPaymentForLiability
800000 usd
CY2023Q2 xcur Class Of Warrant Or Right Number Of Securities Settled In Period
ClassOfWarrantOrRightNumberOfSecuritiesSettledInPeriod
526151 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
50110 shares
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.1031
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
969000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1277000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
21000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0383
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0383
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.010
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.010
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.010
xcur Sharebased Compensation Arrangementby Sharebased Payment Award Fair Value Assumptions Forfeiture Rate
SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsForfeitureRate
0.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q2 us-gaap Share Price
SharePrice
1.58
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.26
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12115 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.28
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
416 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.51
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11699 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y10M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
11699 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M24D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
11699 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y10M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-600000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5764000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1429000 usd
us-gaap Net Income Loss
NetIncomeLoss
-10171000 usd
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8651078 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8651078 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8432394 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8432394 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8650878 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8650878 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7366594 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7366594 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
CY2024Q2 xcur Aggregate Payments Made To Date For License Agreements
AggregatePaymentsMadeToDateForLicenseAgreements
11567000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001698530-24-000089-index-headers.html Edgar Link pending
0001698530-24-000089-index.html Edgar Link pending
0001698530-24-000089.txt Edgar Link pending
0001698530-24-000089-xbrl.zip Edgar Link pending
exicureexhibit311-63024.htm Edgar Link pending
exicureexhibit312-63024.htm Edgar Link pending
exicureexhibit321-63024.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xcur-20240630.htm Edgar Link pending
xcur-20240630.xsd Edgar Link pending
xcur-20240630_def.xml Edgar Link unprocessable
xcur-20240630_lab.xml Edgar Link unprocessable
xcur-20240630_pre.xml Edgar Link unprocessable
xcur-20240630_htm.xml Edgar Link completed
xcur-20240630_cal.xml Edgar Link unprocessable